NCT05138796View on ClinicalTrials.gov

A Pharmacokinetic Study of TP-05 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

67

Participants

Timeline

Start Date

May 6, 2021

Primary Completion Date

March 25, 2022

Study Completion Date

July 25, 2022

Conditions

Healthy

Interventions

DRUG

TP-05 (lotilaner oral capsules)

TP-05 (lotilaner oral capsules)

DRUG

Placebo

Placebo to match TP-05 (lotilaner oral capsules)

Trial Locations (1)

66212

Altasciences, Overland Park

All Listed Sponsors

lead

Tarsus Pharmaceuticals, Inc.

INDUSTRY